Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
主要な著者: | Church, D, Midgley, R, Kerr, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2012
|
類似資料
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
著者:: Midgley, R, 等
出版事項: (2005) -
The emergence of 'omics for the management of colorectal cancer.
著者:: Midgley, R, 等
出版事項: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
著者:: Midgley, R, 等
出版事項: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
著者:: Joao Paulo Solar Vasconcelos, 等
出版事項: (2022-12-01) -
Immunotherapy for colorectal cancer.
著者:: Midgley, R, 等
出版事項: (2003)